Jeff Mihm
Executive-in-Residence, McCombs School of Business
Austin, TX
Mihm was CEO of Noven Pharmaceuticals, a transdermal company. He had an integral role in the sale of Noven to Hisamitsu Pharmaceuticals. He currently serves ass the Executive-in-Residence at the College of Pharmacy and the McCombs School of Business at the University of Texas at Austin.
- March 2023
Added to: Anodyne Nanotech Inc. - Boston, MA
Anodyne Nanotech is a biotechnology company specializing in the transdermal delivery of biologics.
